UN chief pays tribute to the courage of DR Congo citizens facing Ebola and insecurity, and the sacrifice of blue helmets

On the second day of his visit to the Democratic Republic of Congo (DRC), United Nations Secretary-General Ant ónio Guterres saluted the courage of the country’s citizens, as well as the sacrifice of the peacekeepers who have died serving them.
Source: UN News Centre - Health, Poverty, Food Security - Category: International Medicine & Public Health Source Type: news

Related Links:

J. L. Abbate et al.
Source: Emerging Infectious Diseases Journal - Category: Infectious Diseases Source Type: research
[The New Humanitarian] Beni -Anselme Kambale Mungwayitheka thought he was going to die of Ebola a year ago. After contracting the virus and being admitted to an isolation ward, the 40-year-old nurse didn't think he would make it out alive. Nowcured, he says he also feels cursed.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
by Kai J. Rogers, Bethany Brunton, Laura Mallinger, Dana Bohan, Kristina M. Sevcik, Jing Chen, Natalie Ruggio, Wendy Maury BackgroundEbolavirus (EBOV) outbreaks, while sporadic, cause tremendous morbidity and mortality. No therapeutics or vaccines are currently licensed; however, a vaccine has shown promise in clinical trials. A critical step towards development of effective therapeutics is a better understanding of factors that govern host susceptibility to this pathogen. As macrophages are an important cell population targeted during virus replication, we explore the effect of cytokine polarization on macrophage infectio...
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Source Type: research
Emerging tropical viruses have caused serious outbreaks during the recent years, such as Ebola virus (EBOV) in 2014 and the most recent in 2018-19 in Congo. Thus, immediate diagnostic attention is demanded at the point-of-care in resource-limited settings, since the performance and the operational parameters of conventional EBOV testing are limited. Especially, their sensitivity, specificity and coverage of other tropical disease viruses make them unsuitable for diagnostic at the point-of-care. Here, we present a padlock probe (PLP)-based rolling circle amplification (RCA) method for the detection of EBOV.
Source: Journal of Molecular Diagnostics - Category: Pathology Authors: Source Type: research
Swati Gupta ’97 M.P.H. and Anant Shah ’07 M.P.H. are at the forefront of the global fight against Ebola.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
December 10, 2019—BRONX, NY— Researchers atAlbert Einstein College of Medicine secured $178 million from the National Institutes of Health in federal fiscal year 2019, marking the largest annual total in the institution’s history (excluding supplemental stimulus funding distributed as a part of the American Recovery and Reinvestment Act of 2009). Major grants included those to lead international consortiums to study Ebola and HIV, as well as those focusing on neuroscience, genetics, and improving health among minority groups.
Source: Einstein News - Category: Universities & Medical Training Source Type: news
[The New Humanitarian] GOMA, Democratic Republic of Congo -The Democratic Republic of Congo's deadliest ever Ebola outbreak has shown signs of slowing in recent weeks, but militia attacks, anti-UN protests, and chronic community distrust are undermining the 16-month effort to end the epidemic.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Recent occurrences of filoviruses and the arenavirus Lassa virus (LASV) in overlapping endemic areas of Africa highlight the need for a prophylactic vaccine that would confer protection against all of these viruses that cause lethal hemorrhagic fever (HF). We developed a quadrivalent formulation of VesiculoVax that contains recombinant vesicular stomatitis virus (rVSV) vectors expressing filovirus glycoproteins and that also contains a rVSV vector expressing the glycoprotein of a lineage IV strain of LASV. Cynomolgus macaques were vaccinated twice with the quadrivalent formulation, followed by challenge 28 days after the b...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
Two experimental drugs each reduced the risk of death from Ebola when tested in an outbreak in the Democratic Republic of Congo.
Source: NIH Research Matters from the National Institutes of Health (NIH) - Category: Consumer Health News Source Type: news
[New Times] Rwanda and the Democratic Republic of the Congo Sunday unveiled a massive vaccination campaign against Ebola Virus Disease (EVD) for their residents who live within the vicinity of a possible Ebola outbreak.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
More News: Congo Health | Ebola | International Medicine & Public Health | United Nations